Isis Pharmaceuticals (ISIS +2.9%) says it has filed a patent infringement lawsuit against...

|By:, SA News Editor

Isis Pharmaceuticals (ISIS +2.9%) says it has filed a patent infringement lawsuit against Santaris Pharma A/S based upon Santaris' activities providing antisense drugs and antisense drug discovery services to several pharmaceutical companies.